Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Other Accumulated Expenses: 2012-2018

Historic Other Accumulated Expenses for EyePoint Pharmaceuticals (EYPT) over the last 5 years, with Dec 2018 value amounting to $79,000.

  • EyePoint Pharmaceuticals' Other Accumulated Expenses rose 259.09% to $79,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $79,000, marking a year-over-year increase of 259.09%. This contributed to the annual value of $38,000 for FY2018, which is 111.11% up from last year.
  • According to the latest figures from Q4 2018, EyePoint Pharmaceuticals' Other Accumulated Expenses is $79,000, which was up 71.74% from $46,000 recorded in Q3 2018.
  • EyePoint Pharmaceuticals' Other Accumulated Expenses' 5-year high stood at $79,000 during Q4 2018, with a 5-year trough of $7,000 in Q2 2014.
  • Its 3-year average for Other Accumulated Expenses is $44,000, with a median of $47,000 in 2016.
  • In the last 5 years, EyePoint Pharmaceuticals' Other Accumulated Expenses surged by 600.00% in 2014 and then plummeted by 79.17% in 2017.
  • Over the past 5 years, EyePoint Pharmaceuticals' Other Accumulated Expenses (Quarterly) stood at $39,000 in 2014, then plummeted by 64.10% to $14,000 in 2015, then skyrocketed by 307.14% to $57,000 in 2016, then slumped by 61.40% to $22,000 in 2017, then soared by 259.09% to $79,000 in 2018.
  • Its last three reported values are $79,000 in Q4 2018, $46,000 for Q3 2018, and $38,000 during Q2 2018.